Stockreport

Roger Adsett Joins Definium As Commercial Focus Meets Trial Milestones [Yahoo! Finance]

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF Definium Therapeutics (NasdaqGS:DFTX) has appointed biopharma veteran Roger Adsett to its Board of Directors. Adsett brings extensive experience in global drug launch [Read more]